ENLIVEN THERAPEUTICS
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives. The company's discovery process combines clinically validated biological targets and industry-leading chemistry to address the limitations of existing therapies. This approach allows us to efficiently and effectively develop precision oncology therapeutics that enhance overall patient well-being. Founded in July 2019 by Sam Kintz, MBA, Joe Lyssikatos, PhD, and Anish Patel, PharmD, Enliven Therapeutics is based in Boulder, Colorado.
ENLIVEN THERAPEUTICS
Industry:
Biotechnology Life Science Therapeutics
Founded:
2019-01-01
Address:
Boulder, Colorado, United States
Country:
United States
Website Url:
http://www.enliventherapeutics.com
Total Employee:
11+
Status:
Active
Total Funding:
140 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Apache Global Site Tag
Similar Organizations
Affinia Therapeutics
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Alloy Therapeutics
Alloy Therapeutics is a biotech company that makes medicine by democratizing access to foundational drug discovery platforms and services.
Altay Therapeutics
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions.
Black Diamond Therapeutics
Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small molecule.
Calithera Biosciences
Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.
Galera Therapeutics
Galera Therapeutics develops therapeutic agents for preventing damage to normal tissues during the radiation treatment of cancer.
Gallant Pet
Gallant Pet is a pet service company that develops a stem cell therapy intended for dog wounds.
ImmPACT Bio
ImmPACT Bio USA is developing novel cell therapies for treating cancer.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Kanaph Therapeutics
Kanaph Therapeutics is a leading biotech in oncology, auto-immune, and eye diseases with large molecules and small molecules.
MDI Therapeutics
MDI Therapeutics is a operator of an discovery stage company focused on developing novel therapies for fibrotic diseases.
Mitobridge
Mitobridge is discovering and developing small molecule therapeutics that improve mitochondrial functions.
NeuroNascent
Neuronascent discovers and develops small molecule therapeutics for depression and neurodegenerative diseases.
Phoenicis
Phoenicis focuses on developing therapies to provide hope and relief to people living with rare disease.
Restore Vision
Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa.
Scorpion Therapeutics
Scorpion Therapeutics is a precision oncology company that broadens the reach and impact of precision medicine for cancer patients.
Signum Biosciences
Signum Biosciences develops small molecule therapeutics derived from its STM platform to modulate signal transduction imbalances.
SiteOne Therapeutics
SiteOne Therapeutics is a San Francisco-based company that develops novel therapeutics and diagnostics.
Strand Therapeutics
Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.
Synnovation Therapeutics
Synnovation Therapeutics is a precision oncology company that develops therapeutics that aims to help people with cancer.
SyntheX
SyntheX is a biotechnology company reimagining precision therapeutics with new drug discovery technologies focused on protein modulation.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Current Employees Featured
Sam Kintz Co-Founder and CEO @ Enliven Therapeutics
Co-Founder and CEO
2019-01-01
Anish Patel Co-founder and Chief Operating Officer @ Enliven Therapeutics
Co-founder and Chief Operating Officer
Joe Lyssikatos Co-founder and Chief Scientific Officer @ Enliven Therapeutics
Co-founder and Chief Scientific Officer
Founder
Investors List
Surveyor Capital
Surveyor Capital investment in Series B - Enliven Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Enliven Therapeutics
Boxer Capital
Boxer Capital investment in Series B - Enliven Therapeutics
Janus Henderson Investors
Janus Henderson Investors investment in Series B - Enliven Therapeutics
Logos Capital
Logos Capital investment in Series B - Enliven Therapeutics
OrbiMed
OrbiMed investment in Series A - Enliven Therapeutics
Roche Venture Fund
Roche Venture Fund investment in Series A - Enliven Therapeutics
5AM Ventures
5AM Ventures investment in Series A - Enliven Therapeutics
OrbiMed
OrbiMed investment in Seed Round - Enliven Therapeutics
5AM Ventures
5AM Ventures investment in Seed Round - Enliven Therapeutics
Official Site Inspections
http://www.enliventherapeutics.com Semrush global rank: 9.7 M Semrush visits lastest month: 114
- Host name: ec2-54-176-110-96.us-west-1.compute.amazonaws.com
- IP address: 54.176.110.96
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
More informations about "Enliven Therapeutics"
Leadership | Board of Directors | Scientific Advisors | Enliven ...
Anish is a co-founder of Enliven Therapeutics and serves as the Chief Operating Officer. Prior to co-founding Enliven, Anish was the Head of Medical Affairs at AbbVie Stemcentrx, where he …See details»
Enliven Therapeutics - Crunchbase Company Profile
Contact Email info@enliventherapeutics.com Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and …See details»
Enliven Therapeutics Company Overview, Contact Details
Mar 19, 2024 enliventherapeutics hired Lori Kunkel as Board of Directors on Apr 10th '24. BOULDER, Colo., April 09, 2024 (GLOBE NEWSWIRE) - Enliven Therapeutics, Inc. (Enliven …See details»
Enliven Therapeutics Inc Company Profile - Overview - GlobalData
Website www.enliventherapeutics.com Telephone 1 720 6478519. No of Employees 57. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange ELVN (NASD) EPS XYZ. Net …See details»
Enliven Therapeutics - LinkedIn
Enliven Therapeutics | 4,589 followers on LinkedIn. Discovering and developing next generation precision oncology therapeutics | Enliven Therapeutics is a biopharmaceutical company focused on the ...See details»
Enliven Therapeutics 2025 Company Profile: Stock
Enliven Therapeutics General Information Description. Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies.See details»
Org Chart Enliven Therapeutics - The Official Board
For each of our 1,289,706 listed executives, discover their exact roles and their biographies.See details»
Release Details - Enliven Therapeutics
May 11, 2023 Successfully completed merger with Imara Inc., trading under the new ticker symbol on Nasdaq, “ELVN” Dosed first patient in Phase 1 study of ELVN-002 in patients with …See details»
Orphanet: ENLIVEN THERAPEUTICS
E-mail: info@enliventherapeutics.com. Phone 1: +1 (720) 647-8519 Enliven Therapeutics Enliven Therapeutics 6200 Lookout Road 80301 BOULDER CO UNITED STATES. Phone 1: +1 (720) …See details»
Enliven Therapeutics - Overview, News & Similar companies
Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors BOULDER, Colo., April 09, 2024 (GLOBE NEWSWIRE) -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: …See details»
Enliven Therapeutics Inc. - Cruelty Free Investing
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead …See details»
Enliven Therapeutics
Enliven Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule kinase inhibitors for the treatment of various cancers to increase …See details»
Enliven Therapeutics - Craft
Oct 29, 2024 Enliven Therapeutics is a biopharmaceutical company that specializes in cancer treatment solutions. It focuses on discovering and developing small-molecule kinase inhibitor …See details»
Enliven Therapeutics Inc. Company Profile & Executives - WSJ
Company profile for Enliven Therapeutics Inc. including key executives, insider trading, ownership, revenue and average growth rates. View detailed ELVN description & address.See details»
Precision Oncology Therapeutics | Enliven Therapeutics
The Enliven Difference. We strive to improve survival and overall well-being for cancer patients. Despite the advancement of precision medicine in oncology, a significant unmet need remains …See details»
Enliven Therapeutics – Funding, Valuation, Investors, News
Advancing Medicine, Restoring Lives Enliven Therapeutics is a biotechnology company focusing on the discovery and development of next generation precision oncology therapeutics. We are …See details»
ENLIVEN THERAPEUTICS PROVIDES CORPORATE UPDATE ON …
Jan 19, 2022 /PRNewswire/ -- Enliven Therapeutics, Inc. ("Enliven" or the "Company"), a precision oncology company focused on the discovery and development of...See details»
Enliven Therapeutics to Present at the Jefferies London Healthcare ...
BOULDER, Colo., Nov. 7, 2024 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the …See details»
Job Opportunities - Enliven Therapeutics
Jobs Opportunities at Enliven Therapeutics; we foster an inclusive, collaborative culture committed to realizing our mission—to help patients with cancer to not only live longer, but live …See details»
Enliven Therapeutics Reports Fourth Quarter and Full Year 2024
Mar 13, 2025 --Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today reported financial …See details»